Systematic Pediatric Assessment of Rome Criteria (SPARC)
NCT04773158 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33
Last updated 2026-03-13
Summary
While gastroenterologists care for many of the pediatric patients with Functional gastrointestinal disorders (FGIDs), the majority of the burden continues to be borne by general pediatricians, especially with respect to initial diagnosis. Unfortunately, FGIDs are often diagnosed incorrectly by primary care providers, and patients often wait months to years before a correct diagnosis is made, and effective treatment is begun. Furthermore, primary care providers are often unaware of recent guideline changes or the evidence base for children with FGIDs, leading to overuse of testing, inappropriate or ineffective treatment, and increased costs. Given this information, it is essential that we develop interventions that target pediatric primary care providers to improve their care for children with FGIDs. The investigators propose that using a Clinical Decision Support System (CDSS) that incorporates the Rome IV criteria for diagnosis and evidence-based care for FGIDs will improve the (1) accuracy of diagnosis and (2)\_ effectiveness of clinical care. A CDSS has advantages with respect to guideline adherence and automated diagnosis, because it can provide focused, real-time, patient-specific data to the clinician. The investigators hypothesize that automation of screening, diagnosis, and management of FGIDs using the Rome IV criteria will result in improved resolution of FGIDs (primary outcome), as well as decreased utilization of medical services (secondary outcomes). This hypothesis will be tested utilizing a randomized controlled trial. The intervention clinic sites will be provided access to both the FGIDs Screening Module and the Treatment Module. The control clinics will have the FGIDs Screening Module. However, control clinics will not have access to the FGIDs Treatment Module. These clinic sites will be given access to the pre-screener form section of the module, so that providers are made aware of a positive screen.
Conditions
- Functional Gastrointestinal Disorders
Interventions
- BEHAVIORAL
-
Clinical Decision Support
The intervention clinic sites will be provided access to a Clinical Decision Support System (CDSS) that incorporates the Rome IV criteria for evidence-based care recommendations for functional gastrointestinal disorders (FGIDs)
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH -
Indiana University
lead OTHER
Principal Investigators
-
William E Bennett, MD · Indiana University School of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Day
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-22
- Primary Completion
- 2024-05-14
- Completion
- 2025-02-06
Countries
- United States
Study Locations
More Related Trials
-
Functional Gastrointestinal Disorder Screening Program - A Randomized Controlled Trial
NCT01047800 ·Status: COMPLETED ·Phase: NA
-
Postprandial Distress Itopride Cohort Trial
NCT07165301 ·Status: NOT_YET_RECRUITING
-
Evaluation of Food Hypersensitivity in Children/Adolescents With Functional Dyspepsia
NCT00328679 ·Status: COMPLETED ·Phase: PHASE1
-
Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms
NCT04661215 ·Status: RECRUITING
-
Idiopathic Gastroparesis Registry Using a Predominant-Symptom Classification
NCT01173484 ·Status: TERMINATED
-
Preventing Gastric Glitch With Prucalopride and Buspirone: N-of-1 Clinical Trial
NCT05377619 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prevalence of Functional Gastrointestinal Disorders (FGIDs), Related Signs and Symptoms in Infants/Toddlers in Thailand
NCT03608735 ·Status: COMPLETED
-
NLP to Aid in the Evaluation and Diagnosis of FGIDs
NCT05501028 ·Status: ENROLLING_BY_INVITATION
-
Helicobacter in The Gambia (Part 2)
NCT00467155 ·Status: WITHDRAWN
-
Open-Label Placebo for Functional Dyspepsia
NCT03745781 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Trial to Reduce Inappropriate Oesophagogastroduodenoscopies for Dyspepsia
NCT03205319 ·Status: COMPLETED ·Phase: NA
-
Comparison of Outcomes for Single vs Double Pyloromyotomy for Gastroparesis Randomized Controlled Trial
NCT06173336 ·Status: WITHDRAWN ·Phase: NA
-
Clinical Management With SPM System and Validation of the SPM 5 Hour Cutoff in Patients With Symptoms of Gastroparesis
NCT02022826 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Patients With Gastrointestinal Disease
NCT05041374 ·Status: RECRUITING
-
The Predictive Value of Alarm Symptoms in Patients With Dyspepsia Based on Roman IV
NCT03479528 ·Status: UNKNOWN
-
Functional Dyspepsia Microbiome Study
NCT02340312 ·Status: COMPLETED
-
Evaluation of Efficiency of Esophageal Capsule Endoscopy in the Screening of Patients With Gastroesophageal Reflux Disease or Dyspepsia as Compared to Upper Endoscopy
NCT00217347 ·Status: COMPLETED ·Phase: NA
-
A New Method for Determining Gastric Acid Output Using a Wireless Capsule
NCT00702533 ·Status: COMPLETED
-
Assessment of Pyloric Sphincter Physiology
NCT03324074 ·Status: COMPLETED
-
Intestinal Permeability in Children/Adolescents With Functional Dyspepsia
NCT00363597 ·Status: COMPLETED
-
Assessment of Gastric Emptying Speed in Patients Who Experience Diarrhea Following a Trigger Meal
NCT01114113 ·Status: WITHDRAWN ·Phase: NA
-
Endoscopic Pyloromyotomy for Refractory Gastroparesis
NCT03356067 ·Status: COMPLETED ·Phase: NA
-
Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy
NCT02126722 ·Status: UNKNOWN
-
Observational Field Study of Acute Esophageal Food Bolus Impaction by Mean Esophageal Manometry and 24h-pH-monitoring
NCT01447823 ·Status: UNKNOWN
-
G-POEM vs PEG-J in Gastroparesis Patients
NCT06372132 ·Status: RECRUITING ·Phase: NA